Pharmagreen Biotech Inc.
PHBI
$0.0012
$0.00019.09%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 66.44% | -76.60% | 19.33% | -510.36% | 27.77% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -100.00% | -82.29% | 97.10% |
| Total Other Non-Cash Items | -129.47% | 831.75% | 64.93% | 126.66% | -31.51% |
| Change in Net Operating Assets | -21.36% | -28.49% | 10.74% | -22.92% | 22.70% |
| Cash from Operations | 41.49% | 61.98% | 59.02% | 82.40% | 81.05% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 26.95% | -65.59% | -66.55% | -59.15% | -76.40% |
| Total Debt Repaid | -103.85% | -- | -- | -- | 122.81% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 17.55% | -65.79% | -66.75% | -74.85% | -84.05% |
| Foreign Exchange rate Adjustments | -133.33% | 91.46% | -33.24% | -103.37% | -104.49% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 100.41% | 85.51% | 73.16% | -260.47% | -267.59% |
